. .
Clinical Stem 3
A patient with right upper lobe adenocarcinoma progressing on biomarker-directed therapy
Learning Outcome

At the conclusion of the 3rd Clinical Stem webcast, viewers will be able to:
  1. Describe procedural strategies and rationales for molecular testing in patients with enlarging primary NSCLC and associated lymphadenopathy.
  2. Describe how to overcome some of the difficulties encountered while obtaining small samples for molecular analysis.
  3. Describe acquisition and handling techniques to optimize small specimen quality and quantity for molecular testing.
  4. Describe conservation strategies used in obtaining adequate tissue for molecular analysis.